Abstract
Background/Objective
Suicide is a critical health problem that is significantly rising during the COVID-19 pandemic worldwide, yet it is still under-reported in Egypt. To date, a deficiency of a reliable scale to probe the risk factors underlying suicide liability among patients with deliberate self-poisoning. The study’s objective was to offer a snapshot of the pattern of self- poisoning in Egypt during the COVID-19 pandemic.
Methods
Using the Linehan Risk Assessment and Management Protocol LRAMP, a psychological assessment was applied to evaluate vulnerable patients needing urgent psychiatric support and emphasize the influence of previous suicidal behaviors. A cross-sectional study was conducted on all patients admitted to Alexandria Poison Centre with deliberate self-poisoning biosocial and poisoning data that were recorded in a specially designed sheet. All patients were interviewed for underlying risk factors and protective factors for suicidal behavior.
Results
Significant relation was recorded between previous suicidal attempts and psychiatric diseases. CNS depressant drugs and rodenticides recorded the highest frequency. The calculated score (suicide and protective factors) was higher in patients with previous suicidal attempts.
Conclusion
The study was the first to test the applicability of Linehan scale in Alexandria Poison Centre. The results are promising; however, multicenter replication of the concluded findings will be valuable.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) has introduced suicide attempt as a self-initiated sequence of behaviors by a person who, at the time of commencement, anticipated the series of events that would lead to his or her own death [1].
Suicide is a global health issue that is expected to account for more than 700,000 fatalities/year (WHO 2019), and it is the second leading cause of premature deaths among teenagers and young adults [2].
The terms “parasuicide” or “attempted suicide” refer to gestures of self-harm without clear intent of self-harm. Deliberate self-poisoning (DSP) is defined by the WHO as the non-fatal purposeful act of ingesting substances that were not intended for human consumption or of more than a prescribed or accepted therapeutic dose [3].
DSP is used as a means of gaining attention, expressing one’s feelings, or retaliating against someone. Both parasuicides and DSP require the same level of attention as suicide attempts [4].
Suicide risk factors are a dynamic combination of psychological, environmental, social, genetic, and neurobiological factors. One of the strongest indicators of suicide death is a prior suicide attempt [5].
Protective variables are suggested to reduce the likelihood of suicidal behavior while boosting individual’s ability to cope with stress and life difficulties. Internal protective factors include future hope, confidence, life satisfaction, and fear of death. Healthy interpersonal relationships, social support, and a comfortable work environment are considered as external protective factors [6].
Therefore, the ability to assess concurrently risk and protective factors is bound to improve the clinical ability to identify and properly respond to suicide threats.
The actual number of suicide deaths is underestimated globally because non-fatal suicidal behaviors are not always acknowledged due to religious and social considerations, perceived stigmatization, and cultural taboos in many Arabic societies. Consequently, the decedents may attempt to conceal their suicide plans to protect their families emotionally or financially [7].
The absence of a national suicide register and lack of data on suicide in Egypt add a barrier for tracking vulnerable individuals [8].
A significant number of patients with suicidal attempts admitted to the poison center are underestimated regarding the actual suicide risk due to denial or fear of stigmatization in the community. Despite the fact that patients are discharged, the underlying problem remains neglected, and no actual solution is taken to prevent the imminent risk of suicidal attempts in the future. Thus, it is essential to investigate a reliable, easily applicable, and alerting tool to assess these patients and identify the high-risk group.
The lockdown during the COVID-19 pandemic posed additional risks to these vulnerable populations. Being forced out of their comfort zones due to time spent confined at home, while grappled with fear of contagion, insecurity, stress, depression, overuse of social media, and economic crises, has been associated with escalation of suicidality. In addition, during that period, susceptible patients had to overcome additional challenges, such as limited access to mental health services, abuse of medications, or even unprescribed treatment [9].
Back in 2012, Linehan Risk Assessment and Management Protocol (LRAMP) was formulated to better assess and manage suicidal behaviors in clinical settings [10].
The protocol consists of four main sections: the first section specifies the reason of completion and the specific incident/behavior that occurred; the second section includes a check list for acute risk factors of suicide, the nature of population affected, and the existence of proposed protective factors; the third and fourth sections involve the management and subsequent clinical decision-making processes. Therefore, this standardized protocol comprises an organized documentation for assessment and follow-up of individuals with suicidal tendencies [10].
Linehan and his colleagues discovered that persons who had previously expressed suicidal intentions were pessimistic about their current situation compared to those who had never engaged in suicidal behavior [11].
The purpose of this study was to investigate the pattern of poisoning during the COVID-19 pandemic upon suicidal admission to the Alexandria Poison Centre (APC). Secondly, we aimed to undertake a psychological assessment of the studied patients using LRAMP to evaluate its applicability in detecting risk of suicide. The authors proposed that this scale may guide the toxicologist to identify patients susceptible to suicidal risk and could thus advise these individuals to seek psychiatric therapy. Finally, this study intended to evaluate whether a previous history of suicidal attempts could have an impact on both the suicide risk and protective factors.
Subjects
A cross-sectional study was conducted on all patients admitted to APC of the Alexandria Main University Hospital, Egypt, with a history of attempted suicide between the 1st of January 2020 and the 30th of June 2020.
APC is the first specialized toxicological unit in Egypt, established in June 1979, which provides toxicology services to a considerable percentage of intoxicated patients in Egypt, serving approximately 8000 patients/year. APC covers a significantly large area of Alexandria and nearby governorates.
Psychotic patients cognitively unfit patients having difficulty in comprehending the scale, or clinically unstable cases were excluded from this study.
Methods
Measures
This study was approved by the Ethics Committee of the Faculty of Medicine, Alexandria University (Approval serial number: 0304539).
Informed consent was obtained before participation and confidentiality was ensured.
All patients were interviewed, and data, including patients’ detailed history (biosocial data, past medical history of psychiatric illness, and previous suicidal attempts), were recorded in a specially designed sheet. Data related to poisoning, length of hospitalization, and clinical outcome were also documented. All patients were clinically examined.
Causative toxic agents were identified by the toxicologist based on the patients’ history and clinical presentation or by patients’ bringing their medicine/toxic product and revising its label.
Psychological Assessment
Our aim was to help the toxicologist and the emergency physician to diagnose susceptible patients, to make the job more applicable, rapid to implement, feasible, and easy for any general practitioner. Therefore, section two of the scale (suicide risk assessment) was applied. It included a checklist of 15 acute suicide risk factors (current suicide intent, current suicide plan, preferred method currently or easily available, etc.) and a checklist of 11 suicide protective factors (hope for the future, confidence in ability to solve or cope with problems, attachment to life, etc.) [10].
Participants
The interviewer (researcher 4) was trained under the supervision of an experienced assessor skilled in working with suicidal cases (researcher 3). The researcher role-played the test battery with the trainer, who pretended to be suicidal clients at different levels of risk.
The psychological assessment was performed by the same interviewer (researcher 4) upon admission, in a single session. In case of patient fatigue or upon request, short breaks were allowed. The interview lasted approximately 10 to 15 min.
Interpretation
Due to the subjectivity of the instrument, and to simplify the interpretation of the studied items, the section of the scale specific for acute suicide risk factors included 15 questions. Answers were yes, if the patient affirmed the presence of this risk, “no” in case of denial, and “somewhat” if the patient gave no answer or was in doubt and hesitant. The answers were coded as “No” (1 mark), “Somewhat” (2 marks), and “Yes” (3 marks). The risk of suicide was proportional to the overall value obtained from these answers. The greater the number, the greater the risk.
In contrast, coding was reversed for the suicide protective factors: the absence of any protective factor was given a value of 3, “somewhat” was 2, and “yes” was 1. Then, the values from all answers were summed together, and the value was inversely proportional with the presence of protection, i.e., the greater the value, the less the protection offered against suicide.
Statistical Analysis
Qualitative data were described using number and percent. Quantitative data were described using range (minimum and maximum), mean, standard deviation, median, and interquartile range (IQR). The significance level of p value was set at 0.05. Chi-squared test and Fisher’s exact (Monte Carlo correction) were applied to assess data between different groups.
Statistical analysis was performed using IBM SPSS software package version 20.0. (Armonk, NY: IBM Corp).
Results
The study was conducted on 201 patients with age ranging between 10 and 60 years old. 33.9% of the patients were below 20 years old, 41.3% aged from 20 to 30 years old, and 9.5% were above 40 years old. Females represented 73.6% of cases. Patients from urban regions represented 64.2% of admitted cases. History of comorbid organic diseases, such as diabetes, hypertension, cardiac diseases, and hyperthyroidism, was encountered in 18.9% of cases. 27.4% of patients were on medical therapy, such as antidepressant drugs, antipsychotics, mood stabilizers, and antiepileptics. Approximately 15% of all studied cases confirmed a history of previous suicidal attempts (Table 1). A statistically significant relationship was noted between previous suicidal attempts and medications intake, where X2 = 21.2, p < 0.001. Moreover, a significant relationship was noted between previous suicidal attempts and the history of psychiatric diseases, where X2 = 43.4, and p < 0.001 (Table 2).
Ingestion of single and multiple substances was also noted. CNS depressants and rodenticides represented the highest percentage (26.4% and 24.9% respectively) in all age groups and both genders. Regarding patients from urban regions, CNS depressants, analgesics, and other drugs, such as diuretics, antidiarrheals, and laxatives, were most frequently used when attempting suicide (31%, 21.7%, and 20.9%, respectively). In contrast, patients from rural areas frequently used rodenticides and pesticides (37.5% and 27.8%, respectively). Table 3 demonstrates a list of the encountered poisons and presenting symptoms of toxicity.
LRAMP protocol
About three-quarters of the admitted cases (74.6%) stated recent stressful life events. A significant number of cases attempting suicide had access to lethal means and suffered from severe hopelessness or pessimism (45.8% and 48.3%, respectively) (Table 4).
The greatest percentage of patients with previous suicidal attempts have access to lethal means and current severe hopelessness or pessimism (74.2% each), followed by 54.8% of cases who had diminished concentration and impaired decision-making ability, and 51.6% of the cases had perceived burdensomeness. In contrast, 90.3% of the patients with previous suicidal attempts had not been recently discharged from a psychiatric hospital.
The relationship between the acute risk factors of suicide in studied patients according to the presence or absence of previous suicidal behavior was also studied (Table 5).
Regarding the suicidal protective factors, the highest percentage of cases who attempted suicide (86.1%) were not attached to a therapist, counselor, or another service provider, followed by 77.1% of admitted cases that had not attended religious services frequently. Yet, many cases believed that suicide was immoral and that they had hope for the future (69.7% and 63.2%, respectively) (Table 6).
The greatest percentage of patients (87.1%) were afraid of the social disproval of suicide, followed by 64.5% who were frightened of suicide, death, and dying, and 61.3% had confidence in their ability to solve or cope with problems. Significant variables are shown in Table 7.
The mean of the summed acute suicide risk factors was 23.14 with a standard deviation of 4.38. Furthermore, the calculated mean of the suicide protective factors was 23.11 and has a standard deviation of 3.73.
The combination of the suicide risk and protective factors scores ranged from 36 to 66, with a mean of 47.6 and a standard deviation of 6.43. The mean score of suicide risk and protective factors was higher in male patients (48.03 ± 6.4), compared to female patients (47.4 ± 6.3); however, there was no statistically significant difference in the mean scores of suicide risk and lack of protective factors between both sexes, where t = 0.56, and p = 0.572. The mean score of suicide risk and lack of protective factors was the highest among patients who were divorced (52.9 ± 7.1), followed by widows (50.5 ± 0.7), and singles and engaged with nearly equal means (47.3 ± 6.17 and 47.2 ± 6.4, respectively). Notably, the mean score was the lowest among married patients (46.7 ± 6.3). A significant difference was noted in the mean score of suicide risk and lack of protective factors regarding the marital status, Fisher exact test (FE) = 3.09, and p = 0.017.
The mean score of suicide risk and lack of protective factors among patients with previous suicidal attempts was 52.32 ± 5.9, while among patients without previous suicidal attempts was 46.7 ± 6.1. A statistically significant relationship was noted between the mean score of suicide risk and protective factors of patients with previous suicidal attempts, t = 4.6, and p < 0.001.
The relationship between the calculated mean of the acute suicide risk factors and that of protective factors (separately) and age groups, sex of the admitted patients, and the history of previous suicide behavior is shown in Fig. 1.
The duration of hospital stay for cases who had attempted suicide ranged from 4 h to 18 days, with a mean of 1.56 ± 1.72 days. Three patients with aluminum phosphide poisoning were admitted for 10 days for the treatment of the underlying sequelae (ventilator acquired pneumonia and heart failure), and one patient suffered from intermediate syndrome as a complication from organophosphorus poisoning and stayed for 18 days till improvement.
Nearly three-quarters (74.1%) of the admitted cases were completely recovered, 23.9% of the cases were discharged against the medical advice, and only 2% of cases had been discharged with various complications (heart failure and muscle weakness due to poisoning with organophosphates and aluminum phosphide). No deaths were recorded in this study.
In the current study, it was found that the number of suicide cases increased in the second 3 months (the initial period of COVID-19 lockdown in Egypt) more than that of the first 3 months of the 6-month study period (58.7% and 41.3% respectively) (Fig. 2).
Discussion
Various biological, social, and environmental factors have been linked to an increased risk of DSP in the young age group: life stressors, financial crises, and illicit substance abuse. The pubertal onset of depression, impulsivity, lack of family supervision, immature cognitive development, social isolation, and vulnerability to bullying from colleagues are prominent in youth [12,13,14].
The least affected group of individuals included in this study was those above 40 years old, which might be explained by the fact that economic worries decrease with age [15, 16]. Suicide in older patients tends to be underreported due to the negative stigma associated with this act [17]. However, neurocognitive problems and social isolation are considered powerful motivators for ending one’s life [16].
The prevalence of cases among youngsters and early young adults was different from the age groups reported to be affected a few years ago. A retrospective study conducted by Gad ElHak et al. in Port Said, Egypt (1998 to 2004), concluded that 20% of cases were under 20 years of age [18]. In addition, 28% of cases were between 12 and 18 years old in Eldin et al. study in Egypt (2015–2016) [1, 19].
The present study demonstrates a higher percentage of the rate of DSP during the COVID-19 pandemic in younger age groups.
Several studies have identified female gender as a prevalent risk factor for the development of mental health disorders [20, 21]. The results of the current study were consistent with previous studies, such as Ali et al. (2019) in Egypt, Cook et al. (2008) in the UK, and Benedict et al. (2019) in South Africa [22,23,24].
In most underdeveloped countries, females are more vulnerable to aggression and stress [25]. Female suicidal behavior is influenced by limited customs, lack of education, limited job opportunities, and the added weight of being a spinster [26]. COVID-19 lockdowns appear to have created a perfect setting for a rise in violence against women [27].
Suicide rates differ between urban and rural regions. More specifically, the incidence of psychiatric comorbidities, physical ailments, and exposure to psychological stressors is significantly higher with a greater density and diversity in urban populations [28]. Socio-cultural barriers may impede access to medical care and accurate rural reporting of cases [29].
Women in rural areas also have a low level of education and limited social involvement, making it more difficult to deal with stress [25].
The current study demonstrated that more than half of the cases with suicidal behavior were single (55.7%) in agreement with the results of Rezaie et al. (2011) in Iran and Ali et al. (2019) in Egypt [22, 30].
Suicide is more prevalent among singles and individuals who live alone. In other words, having another person in the house might operate as a protective factor by alleviating social isolation and developing a sense of responsibility toward others. The presence of children in the home may also provide more protection for women [31].
Our findings also revealed a statistically significant difference between males and females regarding occupation, in agreement with the study of Ghanem et al. performed in Egypt [32]. Suicide rates among unemployed women were higher compared to the suicide rate among unemployed men within a society where discrimination prevents women from obtaining equal employment prospects [33].
Despite all evidence suggesting that psychiatric disorder is a significant predictor of suicide, a history of psychiatric problems was detected in only 13.9% of the cases analyzed. This discrepancy could be explained by the small sample size, short study duration, and exclusion of other modalities of suicide attempt (such as self-wounding and firearm injuries) [34,35,36].
Furthermore, our study showed that depression was the most common psychiatric disorder among patients with DSP. There is a clear correlation between depressed suicide attempters and increased levels of impulsive and aggressive behavior [25, 37].
Additionally, the current study discovered that 15.4% of cases have a previous history of suicidal attempts. This is consistent with the findings of a study conducted in Iran (2003), where only 7% of suicidal cases had a history of prior suicidal attempt [38].
Antipsychotics, anticonvulsants, and antidepressants were the most reported CNS depressants, followed by rodenticides (zinc phosphide, carbamates, and anticoagulant rodenticides). In general, CNS medications are the most frequently used medicines for self-poisoning in underdeveloped countries [24]. The current findings are consistent with a study conducted on suicide patterns in Northern Tunisia (2005–2015) and another study conducted in Japan (2017), in which psychotropics were the most commonly used drugs for self-poisoning [39, 40].
The widespread usage of antidepressants, including prescription drug overdoses or use of medications belonging to their relatives or acquaintances, could be explained by the fact that depression is common in situations of DSP. The prevalence of CNS depressants in DSP can also be related to the increased rates of depression during the COVID-19 lockdown period [41].
In the current study, the use of rodenticides (24.9%) was more common than pesticides (11.4%), which contradicts the findings from a previous study performed in Northern Tunisia (2005–2015), where pesticides (70.1%) were more commonly used than rodenticides (28.7%) [39].
Recently, the incidence of aluminum phosphide poisoning has been increasing steadily in Egypt, as demonstrated by the study conducted by El-Sarnagawy in 2017 [42]. Low cost and easy accessibility render aluminum phosphide more suitable for suicide; however, our study showed that this accounted for only 8.5%. This may be explained by the fact that the rapid deterioration of patients’ conditions excluded a considerable number of admitted cases.
Over the last years, a noticeable change in the selection of poisons used for suicide among Egyptians has been recorded. A study conducted in one of the largest agriculture cities of Upper Egypt, Assiut (2005–2009), reported that organophosphorus compounds represented 75% of all implicated toxins, and drugs accounted for less than 2% [43]. Similar figures were recorded in the Damietta Governorate (2004–2007), where use of organophosphorus was 69.1% and that of medicinal drugs was less than 5% [44].
Furthermore, CNS depressants were the most frequently used drugs for suicide in patients from urban regions (31%), which is in accordance with the findings of Salah Eldin et al. (2010) in Egypt and Farzaneh et al. (2010) in Iran [19, 45]. In contrast, patients from rural areas often use rodenticides and pesticides. According to Eddleston et al. (2005), pesticide use is widespread form of self-poisoning in rural parts of Sri Lanka (49%) [46].
To conduct a suicide risk assessment, professionals must first obtain information on the long-term risk factors for this condition, such as demographics and medical and family history, and short-term factors, including suicide ideation, planning, and intent. Researchers also need to be aware of the significance of protective factors, which entail social support and the belief that suicide is immoral [47, 48].
The LRAMP was developed to improve clinicians’ ability to diagnose and manage suicide behaviors, reducing clinicians’ anxiety and concerns on the optimal way to treat suicidal individuals. The protocol aimed to reduce assessors’ and providers’ malpractice anxiety by encouraging them to adopt and document standards of care when assessing and managing suicide risk and standardize protocols so that blind assessors could document and apply suicide risk management throughout clinical research assessment regardless of the treatment regimen [10].
The usability and effectiveness of the scale was studied in 2017 by Harned et al., and the results suggested that this scale was associated with significantly improved suicide assessment and management [48].
Concerning acute suicide risk factors, a significant proportion of cases attempting suicide had experienced recent stressful life events during the pandemic, had access to lethal means, and were characterized by severe hopelessness or pessimism. A study conducted in Oman in 2002 revealed that 10.6% of the patients with DSP underperformed in school or that they did not have a good insight into their lives. Chronic illness, bereavement, marital problems, financial troubles, and work stress were also encountered [49].
According to a study conducted in South Africa in 2008, suicide risk factors included relationship problems (55.4%); financial problems (22.9%); psychiatric problems (22.1%); arguments (19.8%); abuse (18.2%); low self-esteem, feelings of worthlessness, hopelessness, or prostration (16.7%); recent life changes (13.2%); unstable family life (9.3%); and academic difficulties (9.3%). A significant portion of these participants had more than one risk factor [50].
Nonetheless, when it comes to protective factors for suicide, a sizable proportion of instances involving DSP feel that suicide is immoral (69.7%) were optimistic regarding their future (63.2%), were attached to life (54.7%), and had social support or connectedness (55.2%).
The mean score of suicide risk and protective factors was the highest among divorced individuals and widows, and the lowest was among married patients. A significant difference was noted in the mean score of suicide risk and protective factors among different marital statuses. The reported findings are consistent with the protective effect of marriage and adhere to the results of previous studies on the protective effect of marital status on suicide [51,52,53].
The mean score of suicide risk and protective factors was significantly higher among patients with previous suicidal attempts. A significant relationship was noted between the mean score of suicide risk and protective factors among patients with previous suicidal attempts. Even when calculating the means separately for each of the suicidal risks and the protective factors, a significant relationship was still reported. These results are in accordance with Chan et al. (2016), who reported that compared to the general population, the risk of suicide increased by 30 to 100 times in the year following a self-harm event [54].
The present study revealed a statistically significant relationship between the acute risk of suicide (calculated mean of the 15 questions proposed) and different age groups, i.e., the mean value increases with age.
These results are in accordance with Ajdacic-Gross et al. (2006) [55] and Mello-Santos et al. (2005) [56], who stated that suicide rates increase with increasing age. This correlation could be explained by known risk factors for suicide in older people, such as physical diseases, grief, social isolation, and loss of income. Therefore, this is consistent with the impact of accumulating disability on the likelihood of suicide [57].
The increase in suicide rates during the COVID-19 lockdown could be explained by many factors, including fear, anxiety and stress during lockdown, and social distancing, loss of employment, increase of domestic violence, and social stigma of being infected, in addition to increase of vulnerability to psychosocial stresses, mental health problems, and suicidal behavior [58, 59].
Our study has certain limitations to be addressed. For instance, this study included a relatively small sample and recruited patients from one poison center, which might have negatively affected our findings. Furthermore, this study was cross-sectional; thus, it provided only an empirical snapshot of suicidality at a certain point of time.
Recommendations
Further studies that will focus on extended durations and will include a larger selection of patients in multiple poison centers are highly recommended to confirm the recorded results and provide database statistics during the COVID-19 pandemic. During pandemics, additional attention must be devoted to vulnerable patient populations, including those susceptible to SARS-CoV-2 (older age, comorbidities) and mentally disturbed individuals.
A concentrated effort between toxicologists and psychiatric physicians is strongly suggested to manage self-poisoning cases.
Owing to the short-term training required, integration of the LRAMP tool into clinical settings should be highly considered. Finally, it is essential to consider the implementation of an integrated multi-specialty poison control center that includes emergency medicine, critical care, pharmacology, pediatrics, psychiatry, preventive medicine, and laboratory diagnostics to manage all poisoned cases and formulate suicide preventive strategies.
Data Availability
Database is available upon request.
Code Availability
Not applicable.
References
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
World Health Organization (WHO). Suicide. Geneva: WHO; 2019.
World Health Organization (WHO). Preventing suicide: a global imperative. Geneva: WHO; 2018.
Els JR, Taljaard L, Strover B. Delayed presentation of paracetamol overdose. Afr J Emerg Med. 2020;10(3):170–2.
Hawton K, Zahl D, Weatherall R. Suicide following deliberate self-harm: long-term follow-up of patients who presented to a general hospital. Br J Psychiatry. 2003;182:537–42.
Kutcher S, Chehil S. Suicide risk management: a manual for health professionals. 2nd ed. United States: John Wiley & Sons, Ltd; 2021.
Rockett IR, Kapusta ND, Bhandari R. Suicide misclassification in an international context: revision and update. Suicidol Online. 2011;2:48–61.
El Halabi S, El Hayek R, Kahil K, Nofal M, El Hayek S. Characteristics of attempted suicide in the middle east and North Africa Region: the mediating role of arab culture and religion. Med JEM. 2020;1(3):3002.
Philip BV. Escalating suicide rates among school children during COVID-19 pandemic and lockdown period: an alarming psychosocial issue. Indian J Psychol Med. 2021;43(1):93–4.
Linehan MM, Comtois KA, Ward-Ciesielski EF. Assessing and managing risk with suicidal individuals. Cognit Behavioral Pract. 2012;19(2):218–32.
Carmel A, Templeton E, Sorenson SM, Logvinenko E. Using the Linehan Risk Assessment and Management Protocol with a chronically suicidal patient: a case report. Cogn Behav Pract. 2018;25(4):449–59.
King RA, Schwab-Stone M, Flisher AJ, Greenwald S, Kramer RA, Goodman SH, et al. Psychosocial and risk behavior correlates of youth suicide attempts and suicidal ideation. J Am Acad Child Adolesc Psychiatry. 2001;40(7):837–46.
Dervic K, Brent DA, Oquendo MA. Completed suicide in childhood. Psychiatr Clin North Am. 2008;31(2):271–91.
Hills AL, Afifi TO, Cox BJ, Bienvenu OJ, Sareen J. Externalizing psychopathology and risk for suicide attempt: cross-sectional and longitudinal findings from the Baltimore Epidemiologic Catchment Area Study. J Nerv Ment Dis. 2009;197(5):293–7.
Koo YW, Kõlves K, De Leo D. Suicide in older adults: differences between the young-old, middle-old, and oldest old. Int Psychogeriatr. 2017;29(8):1297–306.
Conejero I, Olié E, Courtet P, Calati R. Suicide in older adults: current perspectives. Clin Interv Aging. 2018;13:691–9.
Crestani C, Masotti V, Corradi N, Schirripa ML, Cecchi R. Suicide in the elderly: a 37-years retrospective study. Acta Biomed. 2019;90(1):68–76.
Gad ElHak SA, El-Ghazali AM, Salama MM, Aboelyazeed AY. Fatal suicide cases in Port Said city. Egypt J Forensic Leg Med. 2009;16(5):266–8.
Salah Eldin H, Azim S. Pattern of deliberate self-poisoning cases admitted to Poison Control Center Ain Shams University Hospitals during the years 2015–2016. Ain Shams J Forensic Med Clin Toxicol. 2018;30(1):9–17.
Hossain MM, Tasnim S, Sultana A, Faizah F, Mazumder H, Zou L, et al. Epidemiology of mental health problems in COVID-19: a review. F1000Res. 2020;9:636.
Li G, Miao J, Wang H, Xu S, Sun W, Fan Y, et al. Psychological impact on women health workers involved in COVID-19 outbreak in Wuhan: a cross-sectional study. J Neurol Neurosurg Psychiatry. 2020;91(8):895–7.
Ali AR, Eldesoky MM, Gaballa IF, Abd Elsatar MF. Prospective evaluation of suicide cases presented to national environmental and clinical toxicology center - Egypt. Toxi App Phar Insig. 2019;2(1):1–11.
Cook R, Allcock R, Johnston M. Self-poisoning: current trends and practice in a U.K. teaching hospital. Clin Med (Lond). 2008;8(1):37–40.
Benedict MOA, Van Loggerenberg C, Steinberg W. The profile of deliberate self-poisoning cases presenting at the emergency department of Pelonomi Regional Hospital. Bloemfontein S Afr Fam Pract. 2019;61(1):11–7.
Zhang J, Xiao S, Zhou L. Mental disorders and suicide among young rural Chinese: a case-control psychological autopsy study. Am J Psychiatry. 2010;167(7):773–81.
El-Farouny RH. Suicidal self poisoning and its relation with personality traits among admitted cases to menoufia poisoning control center. Egypt J Forensic Sci Appli Toxicol. 2021;21(1):13–30.
Evans ML, Lindauer M, Farrell ME. A pandemic within a pandemic - intimate partner violence during COVID-19. N Engl J Med. 2020;383(24):2302–4.
Qin P. Suicide risk in relation to level of urbanicity–a population-based linkage study. Int J Epidemiol. 2005;34(4):846–52.
Khan MM, Hyder AA. Suicides in the developing world: case study from Pakistan. Suicide Life Threat Behav. 2006;36(1):76–81.
Rezaie L, Khazaie H, Soleimani A, Schwebel DC. Is self-immolation a distinct method for suicide? A comparison of Iranian patients attempting suicide by self-immolation and by poisoning. Burns. 2011;37(1):159–63.
Jacobs DG, Baldessarini RJ, Conwell Y, Fawcett JA, Horton L, Meltzer H, et al. Practice guideline for the assessment and treatment of patients with suicidal behaviors. USA: American Psychiatric Association; 2010.
Ghanem M, Gamaluddin H, Mansour M, Samiee AA, Shaker NM, El Rafei H. Role of impulsivity and other personality dimensions in attempted suicide with self-poisoning among children and adolescents. Arch Suicide Res. 2013;17(3):262–74.
Durkheim E. Suicide: a study in sociology. New York: The Free Press; 1979.
Nock MK, Borges G, Bromet EJ, Alonso J, Angermeyer M, Beautrais A, et al. Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry. 2008;192(2):98–105.
Nock MK, Hwang I, Sampson NA, Kessler RC. Mental disorders, comorbidity and suicidal behavior: results from the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(8):868–76.
Bertolote JM, Fleischmann A. A global perspective in the epidemiology of suicide. Suicidologi. 2002;7(2):6–8.
Becker DF, Grilo CM. Prediction of suicidality and violence in hospitalized adolescents: comparisons by sex. Can J Psychiatry. 2007;52(9):572–80.
Shadnia S, Esmaily H, Sasanian G, Pajoumand A, Hassanian-Moghaddam H, Abdollahi M. Pattern of acute poisoning in Tehran-Iran in 2003. Hum Exp Toxicol. 2007;26(9):753–6.
Gharbaoui M, Ben Khelil M, Harzallah H, Benzarti A, Zhioua M, Hamdoun M. Pattern of suicide by self-poisoning in Northern Tunisia: an eleven-year study (2005–2015). J Forensic Leg Med. 2019;61:1–4.
Takeuchi T, Takenoshita S, Taka F, Nakao M, Nomura K. The relationship between psychotropic drug use and suicidal behavior in Japan: Japanese adverse drug event report. Pharmacopsychiatry. 2017;50(2):69–73.
Racine N, McArthur BA, Cooke JE, Eirich R, Zhu J, Madigan S. Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a meta-analysis. JAMA Pediatr. 2021;175(11):1142–50.
El-Sarnagawy G. Predictive factors of mortality in acute aluminum phosphide poisoning: 5 years retrospective study in Tanta Poison Control Unit. Ain Shams J Forensic Med Clin Toxicol. 2017;29(2):70–9.
Abdel Moneim WM, Yassa HA, George SM. Suicide rate: trends and implications in upper Egypt. Egypt J Forensic Sci. 2011;1(1):48–52.
Shreed S, Tawfik N, Mohammed N, Elmahdi M. Toxic agents used for parasuicide in Damietta Governorate. Egypt Middl East Current Psychiat. 2011;18(1):11–7.
Farzaneh E, Mehrpour O, Alfred S, Moghaddam HH, Behnoush B, Seghatoleslam T. Self-poisoning suicide attempts among students in Tehran. Iran Psychiatr Danub. 2010;22(1):34–8.
Eddleston M, Gunnell D, Karunaratne A, de Silva D, Sheriff MH, Buckley NA. Epidemiology of intentional self-poisoning in rural Sri Lanka. Br J Psychiatry. 2005;187:583–4.
Rudd MD. The assessment and management of suicidality. Sarasota, FL: Professional Resource Press; 2006.
Harned MS, Lungu A, Wilks CR, Linehan MM. Evaluating a multimedia tool for suicide risk assessment and management: the Linehan Suicide Safety Net. J Clin Psychol. 2017;73(3):308–18.
Zaidan ZA, Burke DT, Dorvlo AS, Al-Naamani A, Al-Suleimani A, Al-Hussaini A, et al. Deliberate self-poisoning in Oman. Trop Med Int Health. 2002;7(6):549–56.
Du Toit EH, Kruger JM, Swiegers SM, Van der Merwe M, Calitz FJW, Philane L, et al. The profile analysis of attempted-suicide patients referred to Pelonomi Hospital for psychological evaluation and treatment from 1 May 2005 to 30 April 2006. S Afr J Psychiatr. 2008;14(1):20–6.
Corcoran P, Nagar A. Suicide and marital status in Northern Ireland. Soc Psychiatry Psychiatr Epidemiol. 2010;45(8):795–800.
Yeh JY, Xirasagar S, Liu TC, Li CY, Lin HC. Does marital status predict the odds of suicidal death in taiwan? A seven-year population-based study. Suicide Life Threat Behav. 2008;38(3):302–10.
Masocco M, Pompili M, Vichi M, Vanacore N, Lester D, Tatarelli R. Suicide and marital status in Italy. Psychiatr Q. 2008;79(4):275–85.
Chan MK, Bhatti H, Meader N, Stockton S, Evans J, O’Connor RC, et al. Predicting suicide following self-harm: systematic review of risk factors and risk scales. Br J Psychiatry. 2016;209(4):277–83.
Ajdacic-Gross V, Bopp M, Gostynski M, Lauber C, Gutzwiller F, Rössler W. Age-period-cohort analysis of Swiss suicide data, 1881–2000. Eur Arch Psychiatry Clin Neurosci. 2006;256(4):207–14.
Mello-Santos C, Bertolote JM, Wang YP. Epidemiology of suicide in Brazil (1980–2000): characterization of age and gender rates of suicide. Braz J Psychiatry. 2005;27(2):131–4.
Case A, Deaton A. Suicide, age, and wellbeing: an empirical investigation. In: Wise DA, editor. Insights in the Economics of Aging. Chicago: University of Chicago Press; 2017. p. 307–34.
Sher L. Psychiatric disorders and suicide in the COVID-19 era. QJM. 2020;113(8):527–8.
Reger MA, Stanley IH, Joiner TE. Suicide mortality and coronavirus disease 2019-a perfect storm? JAMA Psychiat. 2020;77(11):1093–4.
Author information
Authors and Affiliations
Contributions
Study design and conceptualization was conducted by all authors. HF conducted the study design, study supervision, and critical final revision of the manuscript. AA contributed to the conduct of the psychological assessment part of the methodology. RH was involved in data collection, interviewing patients, analysis, and interpretation of data. FB, WK, and RH were involved in the analysis and interpretation of data, reviewing the literature, drafting, and revising the manuscript.
Corresponding author
Ethics declarations
Ethics Approval
Ethics Committee of the Faculty of Medicine, Alexandria University approved the study (Approval serial number: 0304539).
Consent to Participate
Informed consent was obtained before participation.
Consent for Publication
All authors approved the final manuscript for publication.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points
1. People who have a history of suicidal behavior are at a greater risk of attempting suicide in the future.
2. The LRAMP scale appears to be a useful tool for the identification of vulnerable patients, and it is independent of previous psychiatric opinions regarding the specific case.
3. The application of the structured questionnaire, which includes both risk and protective factors, does not necessitate a high level of qualification or psychiatric expertise.
4. Educational training can improve the ability of multidisciplinary care providers to identify and manage the risk of suicide outside conventional mental health services.
This article is part of the Topical Collection on Covid-19
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Abd El Salam, H.F., Badr El Dine, F.M.M., Abd El Kerim, A.M. et al. The Applicability of Linehan Risk Assessment Scale: a Cross-Sectional Study from Alexandria Poison Centre, Egypt, During the COVID-19 Pandemic. SN Compr. Clin. Med. 4, 218 (2022). https://doi.org/10.1007/s42399-022-01298-8
Accepted:
Published:
DOI: https://doi.org/10.1007/s42399-022-01298-8